The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease.

The global Drugs for Central Nervous System market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Drugs for Central Nervous System volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drugs for Central Nervous System market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Drugs for Central Nervous System in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Drugs for Central Nervous System manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Biogen
Pfizer
Teva
Novartis
Johnson & Johnson
Eli Lilly 
Otsuka
Merck
AstraZeneca
Novartis
Shire

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
OTC
Rx Drugs

Segment by Application
Hospital
Retail Pharmacy